Table 4. Lenvatinib-related AEs.

AEs	All grade n (%)	Grade 3 n (%)	Grade 4 n (%)
Rash	6 (20.0)	1 (3.3)	0
Hypertension	5 (16.7)	2 (6.7)	0
Diarrhea	4 (13.3)	0	0
Decreased appetite	3 (10.0)	0	0
Fatigue	3 (10.0)	0	0
Hand-foot skin reaction	2 (6.7)	0	0
Stomachache	2 (6.7)	0	0
Oral ulcer	2 (6.7)	0	0
Myalgia	1 (3.3)	0	0
Vomiting	1 (3.3)	0	0
Obstructive jaundice	1 (3.3)	0	1 (3.3)
Epistaxis	1 (3.3)	0	0
Gingival bleeding	1 (3.3)	0	0

AEs, adverse events.